Evidence map›Paper›PMID 29907857›Full record

ArticleScientific reports2018

Alterations of mTOR signaling impact metabolic stress resistance in colorectal carcinomas with BRAF and KRAS mutations.

Raphaela Fritsche-Guenther, Christin Zasada, Guido Mastrobuoni, Nadine Royla, Roman Rainer, Florian Roßner, Matthias Pietzke, Edda Klipp, Christine Sers, Stefan Kempa

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Serum Starvation Accelerates Intracellular Metabolism in Endothelial Cells.International journal of molecular sciences · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Effect ofFrontiers in genetics · 2022
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Raphaela Fritsche-GuentherMax-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Institute of Health (BIH), Robert-Roessle-Str. 10, 13125, Berlin, Germany.
Christin ZasadaMax-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Institute for Medical Systems Biology (BIMSB), Robert-Roessle-Str. 10, 13125, Berlin, Germany.
Guido MastrobuoniMax-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Institute for Medical Systems Biology (BIMSB), Robert-Roessle-Str. 10, 13125, Berlin, Germany.
Nadine RoylaMax-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Institute for Medical Systems Biology (BIMSB), Robert-Roessle-Str. 10, 13125, Berlin, Germany.
Roman RainerHumboldt University Berlin, Theoretical Biophysics, Invalidenstraße 42, 10115, Berlin, Germany.
Florian RoßnerCharité Universitätsmedizin, Institute of Pathology, Chariteplatz 1, 10117, Berlin, Germany.
Matthias PietzkeBeatson Institute, Switchback Road, Bearsden, Glasgow, G61 1BD, United Kingdom.
Edda KlippCharité Universitätsmedizin, Institute of Pathology, Chariteplatz 1, 10117, Berlin, Germany.ORCID 0000-0002-0567-7075
Christine SersCharité Universitätsmedizin, Institute of Pathology, Chariteplatz 1, 10117, Berlin, Germany.
Stefan KempaMax-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Institute of Health (BIH), Robert-Roessle-Str. 10, 13125, Berlin, Germany. stefan.kempa@mdc-berlin.de.
Max Delbrück Center · DECharité - Universitätsmedizin Berlin · DECancer Research UK Scotland Institute · GBHumboldt-Universität zu Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolic reprogramming is as a hallmark of cancer, and several studies have reported that BRAF and KRAS tumors may be accompanied by a deregulation of cellular metabolism. We investigated how BRAF

Indexed as

Mutation, MissenseSignal TransductionStress, PhysiologicalAmino Acid SubstitutionAMP-Activated Protein KinasesAnimalsCaco-2 CellsColorectal NeoplasmsGlycolysisHumansLactic AcidMaleMiceModels, BiologicalProto-Oncogene Proteins B-rafProto-Oncogene Proteins c-aktAMP-Activated Protein KinasesBRAF protein, humanKRAS protein, humanLactic AcidMTOR protein, humanProto-Oncogene Proteins B-rafProto-Oncogene Proteins c-aktProto-Oncogene Proteins p21(ras)TOR Serine-Threonine Kinases

Identifiers

PMID29907857
PMCPMC6003911
OpenAlexW2807784338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.